Eleanor Wilson, MD, MHS

Moderna, Inc.
Cambridge, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• 223 - Safety, Tolerability, and Immunogenicity of the mRNA-1345 RSV Vaccine in Solid Organ Transplant Recipients Aged ≥18 Years

  Monday, October 20, 2025
  4:15 PM - 4:27 PM US ET

• 229 - mRNA-1010, an mRNA-Based Influenza Vaccine, is Safe and Efficacious in Adults Aged ≥50 Years

  Monday, October 20, 2025
  4:15 PM - 4:27 PM US ET